![](https://theceopublication.com/wp-content/uploads/2024/09/Foster-USA-Wins-Winston-Salem-Council-Approval-for-Incentives.png)
November 4, 2021: -In Theranos, a former estate attorney told jurors in Elizabeth Holmes’ criminal trial that he invested $6 million after being introduced to Holmes by ex-Secretary of State Henry Kissinger.
In week nine of the trial, Daniel Mosley, counting Kissinger as a client, took the stand on Tuesday. He then said that he first heard of the blood-testing start-up in 2013 through Kissinger, one of the few high-profile former government officials on the Theranos board.
“Dr. Kissinger explaining to me he was on the board of Theranos and that it was an exciting company,” Mosely said. “He said it would be terrific if you would take the time to learn regarding the company and give me your views on it.”
Mosley testified that Holmes looks for “high-quality families” to invest. While his conversations with Holmes, Mosley said he started evaluating a potential investment for himself.
“I will look at it with an intent to tell Dr. Kissinger what I thought about it,” Mosley said, adding that he found it to be “personally interesting.”
Holmes is fighting ten counts of wire fraud and two counts of conspiracy to commit wire fraud. Federal prosecutors allege Holmes and co-conspirator Ramesh “Sunny” Balwani swindled hundreds of millions of dollars from investors while knowingly misleading doctors and patients with claims of revolutionary blood-testing technology. Both have pleaded not guilty.
Prosecutors showed a binder given to Mosley, and it included the promises Theranos made to investors. One slide said, “Theranos has been comprehensively validated over the last seven years by 10 of the 15 largest pharmaceutical companies, with hundreds of thousands of assays processed.”
Mosley added that he knew it was a risky bet and that investing in a start-up meant he could lose his money. But he also said he believed the data he was shown.
© THE CEO PUBLICATION 2021 | All rights reserved. Terms and condition | Privacy and Policy